An interventional study of CTB and CMA in CLASS II DIVISION 1 MALOCCLUSION, Class II Malocclusion and Growth, sponsored by Aslam Alkadhimi. Not yet recruiting at 1 site in Ireland. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2025-12-18.
Sponsored by Aslam Alkadhimi · Not applicable, Interventional, and Treatment
The investigators of this clinical trial aim to:
Class II division 1 malocclusion is a dental condition where the upper teeth protrude significantly over the lower teeth. It is a common type of malocclusion observed in orthodontic practice, accounting for approximately 20-25% globally. Correcting Class II malocclusion in growing patients using functional appliances and Class II correctors is relatively predictable.
In Ireland and the United Kingdom, the Clark's Twin Block (CTB) is the most commonly used functional appliance. The CTB consists of two components: one for the upper teeth and one for the lower teeth. These components are engineered to position the lower jaw forward, thereby promoting the desired dentoskeletal changes (moving the upper teeth back and lower forward). Another device used for Class II correction is the Carriere Motion Appliance (CMA). The CMA is gaining popularity as a treatment option for Class II malocclusion, inducing dental changes similar to those achieved with a CTB. However, uncertainty persists regarding the effectiveness of these appliances in older adolescents in the post-pubertal growth phase (aged approximately 14.5 years or above).
Additionally, although both CTB and CMA are effective in growing patients in correcting dental and skeletal discrepancies, they may influence daily activities, comfort, and psychological aspects, which often results in poor compliance. Poor adherence to orthodontic treatment, whether with fixed or removable appliances, can lead to higher rates of treatment failure.
Introduction:
Multiple treatment approaches are available to address the Class II byccal segment relationship characteristic of this type of malocclusion. However, the treatment approach depends on various factors, with chronological and skeletal age being pivotal. Typically, patients present with an underlying Class II skeletal pattern characterised by mandibular retrusion.
In growing patients, treatment often involves growth-dependent strategies, such as functional appliances or other Class II correctors. While these approaches primarily produce dentoalveolar effects, with less than one-third of the correction achieved by functional appliances attributable to skeletal changes, understanding the distinction between skeletal and dentoalveolar impacts is crucial. This differentiation informs treatment choice by highlighting the varying degrees to which these methods can achieve skeletal versus dental corrections, essential for tailoring patient-specific plans.
A continuing discussion exists regarding the ability of functional appliances, whether removable or fixed, to provide effective short- and long-term stimulation of mandibular growth. While this discussion endures, it is widely recognised that the majority of correction achieved with these appliances tends to be dentoalveolar rather than skeletal in nature, with only a modest proportion attributable to true mandibular advancement. Furthermore, these dentoalveolar effects are not exclusive to functional appliances, as similar outcomes have been documented with alternative Class II correctors such as the Carriere Motion Appliance, as detailed in subsequent studies.
Some researchers propose that functional appliances yield favourable outcomes by promoting mandibular growth, either through increased mandibular length or condylar growth. Conversely, other studies contend that the extent of these skeletal effects is limited. Consequently, substantial evidence indicates that dentoalveolar changes resulting from functional appliance treatment exceed the skeletal changes.
Correcting Class II malocclusion in growing patients using functional appliances and Class II correctors is relatively predictable. However, uncertainty persists regarding the effectiveness of these appliances in older adolescents in the post-pubertal growth phase (aged approximately 14.5 years or above). Limited evidence from two retrospective studies suggests that CTB and fixed functional appliances remain effective in patients with mean ages of 13.73 ± 1.51 years and 13.76 ± 1.44 years, respectively. Furthermore, a recent randomised controlled trial (RCT) demonstrated that CTB yielded comparable effects in patients aged 11 years 8 months to 12 years 8 months, relative to those who initiated treatment 18 months later. However, the interval of active treatment between the immediate treatment group and the later treatment group may not have been sufficient to reveal significant differences in treatment outcomes. The delay for the late-treatment group was constrained by the current waiting list durations in this study.
There is a notable lack of literature regarding the effectiveness of functional appliances and other Class II correctors in post-pubertal patients.
Oral Health Related Quality of Life associated with Class II and its treatment Although both CTB and CMA are effective in growing patients in correcting dental and skeletal discrepancies, they may influence daily activities, comfort, and psychological aspects, which often results in poor compliance. Poor adherence to orthodontic treatment, whether with fixed or removable appliances, can lead to higher rates of treatment failure. To address these compliance challenges, our study will use wear-time sensors in the CTBs to objectively monitor appliance adherence.
Several generic measures are used to assess oral health-related quality of life (OHRQoL) across various dental conditions. One such measure is the Child Oral Health Impact Profile (COHIP), which is also available in a short form (COHIP-19). This questionnaire is a reliable and valid tool for assessing OHRQoL in patients aged 7 to 18 years.
However, generic measures may not fully capture condition-specific impacts. To address this limitation, condition-specific OHRQoL measures have been developed. The Malocclusion Impact Questionnaire (MIQ), initially developed and tested in the UK, provides a targeted assessment of the effects of malocclusion on young patients. The Orthodontic Treatment Impact Questionnaire (OTIQ) evaluates the daily impact of orthodontic appliances on adolescents and demonstrates strong construct validity, reliability, and internal consistency.
Statement of the problem:
The effectiveness of functional appliances and Class II correctors in treating Class II malocclusion is well known. However, treating older adolescents in the post-pubertal skeletal growth phase presents certain challenges that we aim to address:
Importance of this research:
Objectives:
The objectives of this clinical trial are to:
Hypotheses:
124 studies on the registry are indexed under Malocclusion, Angle Class II; 19 are open to participants now.
This study's planned enrollment of 88 is above the median of 34 across 115 interventional studies indexed under Malocclusion, Angle Class II.
Browse Malocclusion, Angle Class II studies →This is the only study on the registry with Aslam Alkadhimi as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants assigned to this group will receive CTB.
Device: CTB
Participants assigned to this group will receive CMA.
Device: CMA
The appliance will be used with the bite registration taken in maximum protrusion incorporating the following features: (1) Adam's clasps on all first premolars and first permanent molars, (2) three ball-ended clasps on the mandibular incisors, (3) midline expansion screw in the maxillary component, (4) blocks intersecting at 70 degrees, with a height of 5-6 mm in the premolar region. Patients will be instructed to wear the appliance full-time, except for eating, and during contact or water sports. Objective wear time in minutes will be recorded by a Theramon® microsensor (Handelsagentur Gschladt, Hargelsberg, Austria, or Forestadent, Pforzheim, Germany) placed in the maxillary component.
The appliance consists of rigid stainless-steel or acrylic bars bonded to the maxillary canines and first molars bilaterally. Elastics will be worn in a Class II pattern, from hooks on the maxillary canine to attachments on the mandibular first molar (bonded molar tubes). Anchorage in the mandibular dentition will be provided by an Essix-type retainer. Patients will be instructed to wear elastics full time except for eating and cleaning the teeth. The elastics protocol for the CMA appliance will be: Force 1 elastics (Henry Schein Orthodontics) that generate about 375 g of force that will be used during the first 6 weeks, changed to Force 2 elastics that generate about 540 g of force thereafter.
Change in molar and canine relationship at T3 (effectiveness)
The primary outcome measure (change in molar and canine relationship) will be calculated at T3. This will be calculated by measuring the difference from T0 to T3 in the horizontal plane (in mm); * from the cusp tip of maxillary canine relative to the distal contact point of the opposing mandibular canine (change in canine relationship) and * from the mesiobuccal cusp of maxillary first molar relative to the buccal groove of mandibular first molar (change in molar relationship). All the measurements will be performed on dental study casts (taken at T0 and T3) articulated in maximum intercuspation position (MIP) using a vernier calliper. Measurements from right and left sides will be taken. Change in the canine and molar relationship will be calculated as the difference from T0 to T3.
Time frame: T3: 9 months
Change in molar and canine relationship at T2 (efficiency)
The secondary outcome measure (change in molar and canine relationship) will be calculated at T2. This will be calculated by measuring the difference from T0 to T2 in the horizontal plane (in mm); * from the cusp tip of maxillary canine relative to the distal contact point of the opposing mandibular canine (change in canine relationship) and * from the mesiobuccal cusp of maxillary first molar relative to the buccal groove of mandibular first molar (change in molar relationship). All the measurements will be performed on intra-orally (taken at T0 and T2) using a vernier calliper. Measurements from right and left sides will be taken.
Time frame: T2: 18 weeks
Dentoskeletal cephalometric changes at T3
Cephalometric dentoskeletal measurements (sagittal maxillary skeletal, sagittal mandibular skeletal, angular maxillomandibular, vertical skeletal and dentoalveolar). Each T0 and T3 lateral cephalogram will be obtained from the same machine and will be analysed by orienting it so that the Frankfurt plane is parallel to the floor, with the same magnification factor.
Time frame: T3: 9 months
Impact of treatment on daily life based on the Orthodontic Treatment Impact Questionnaire (OTIQ) scores at T1 and T3
Evaluate potential negative oral health-related quality of life impacts during the active treatment phase with either CTB or CMA in post-pubertal adolescents. The Orthodontic Treatment Impact Questionnaire (OTIQ) is used to assess the day-to-day impact of any orthodontic appliance on adolescents, possessing good construct validity, reliability, and internal consistency. The OTIC score ranges from 0 to 44. Higher scores on the OTIQ indicate lower OHRQoL.
Time frame: T1: 2 weeks; T3: 9 months
Impact of Class II correction on oral health-related quality of life (OHRQoL) based on the Malocclusion Impact Questionnaire (MIQ) scores at T0 and T4
The impact of Class II malocclusion on oral health-related quality of life (OHRQoL) in post-pubertal adolescents, will be investigated. The Malocclusion Impact Questionnaire (MIQ) will be used to assess this outcome. MIQ score ranges from 0 to 34. Higher MIQ scores indicate greater negative impact of malocclusion on OHRQoL.
Time frame: T0: Baseline; T4: 42 weeks
Impact of Class II correction on oral health-related quality of life (OHRQoL) based on the Child Oral Health Impact Profile (COHIP-19) scores at T0 and T4
The impact of Class II malocclusion on oral health-related quality of life (OHRQoL) in post-pubertal adolescents, will be investigated. The Child Oral Health Impact Profile (COHIP), available as a short form (COHIP-19) will be used to assess this outcome. COHIP-19 score ranges from 0 to 76. Higher COHIP-19 score indicate greater OHRQoL.
Time frame: T0: Baseline; T4: 42 weeks
Plan to share: Yes — There is a plan to make IPD and related data dictionaries available after trial completion.
Supporting information: Study protocol, Statistical analysis plan
Time frame: After trial completion.
Access criteria: Journal editors upon request.
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Malocclusion, Angle Class II →